Ignite Creation Date:
2025-12-26 @ 5:18 PM
Ignite Modification Date:
2025-12-31 @ 1:25 PM
Study NCT ID:
NCT02149706
Status:
UNKNOWN
Last Update Posted:
2020-03-11
First Post:
2014-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis
Sponsor:
Immune Response BioPharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-03-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-03-09
Completion Date Type:
ESTIMATED
First Submit Date:
2014-05-24
First Submit QC Date:
None
Study First Post Date:
2014-05-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-09
Last Update Post Date:
2020-03-11
Last Update Post Date Type:
ACTUAL